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ABSTRACT 
Emotional processing dysfunction is widely reported in patients with chronic 
schizophrenia and first-episode psychosis (FEP), and has been linked to functional 
abnormalities of corticolimbic regions. However, corticolimbic dysfunction is less 
studied in people at ultra-high risk for psychosis (UHR), particularly during processing 
prosodic voices. We examined corticolimbic response during an emotion recognition task 
in 18 UHR participants and compared them with 18 FEP patients and 21 healthy controls 
(HC). Emotional recognition accuracy and corticolimbic response were measured during 
functional magnetic resonance imaging (fMRI) using emotional dynamic facial and 
prosodic voice stimuli. Relative to HC, both UHR and FEP groups showed impaired 
overall emotion recognition accuracy. Whilst during face trials, both UHR and FEP 
groups did not show significant differences in brain activation relative to HC, during 
voice trials, FEP patients showed reduced activation across corticolimbic networks 
including the amygdala. UHR participants showed a trend for increased response in the 
caudate nucleus during the processing of emotionally valenced prosodic voices relative to 
HC. The results indicate that corticolimbic dysfunction seen in FEP patients is also 
present, albeit to a lesser extent, in an UHR cohort, and may represent a neural substrate 
for emotional processing difficulties prior to the onset of florid psychosis.  
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1. INTRODUCTION 
Emotional processing deficits are widely reported in patients with schizophrenia and 
first-episode psychosis (FEP). Experimental studies, using both emotional faces and 
prosodic voice stimuli, report robust emotion recognition deficits in patients with 
schizophrenia and FEP (Edwards et al., 2002; Edwards et al., 2001; Thompson et al., 
2012; Tseng et al., 2013). As in established schizophrenia, deficits in facial and prosodic 
emotion recognition have also been demonstrated in UHR populations (Addington et al., 
2012; Amminger et al., 2012a; Amminger et al., 2012b; Thompson et al., 2012) 
indicating that impairments in emotional recognition and processing are already apparent 
in the prodromal phase of the illness. This is consistent with the emotional dysfunction, in 
the form of anxiety and affective symptoms, that is common in people who are at ultra-
high risk (UHR) for developing psychosis (Yung et al., 2003). 
 
Dysfunction in brain regions important for emotional processing may be associated with 
vulnerability for developing the illness and may exist before the onset of florid psychosis 
(Barbour et al., 2012; Bediou et al., 2007; Eack et al., 2010; Habel et al., 2004). 
Neuroimaging studies in patients with schizophrenia and FEP (Lee et al., 2002; Li et al., 
2010; Pinkham et al., 2005; Reske et al., 2009) have identified impairments during facial 
and prosodic emotional processing in cortical and limbic structures, including: the 
fusiform gyrus (FG) for facial expressions; superior temporal gyrus (STG) for vocal 
prosodies; amygdala; anterior cingulate gyrus and ventral and medial prefrontal cortex 
for both (Bach et al., 2009; Gur et al., 2002; Hempel et al., 2003; Li et al., 2010; Mitchell 
and Crow, 2005; Mitchell et al., 2004; Williams et al., 2004). Dysfunction in these 
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regions is thought to account for patients’ characteristic disturbances in facial and 
prosodic emotional processing and recognition (Gur et al., 2002; Williams et al., 2004).  
 
A multi-stage model of emotional perception and recognition has been proposed by 
Wildgruber (Wildgruber et al., 2009). The model postulates that in an initial sensory 
processing stage, the FG and STG extract basic features from visual and speech input 
(stage 1).  This emotional information is then conveyed to higher order emotional 
processing areas (i.e. amygdala, parahippocampal area, inferior frontal cortex) for 
evaluation. Neuroimaging findings in chronic schizophrenia and FEP patients suggest 
neural dysfunction is present at both stages of the putative model (Leitman et al., 2007; 
Li et al., 2010; Mitchell et al., 2004), i.e. in emotional perception and evaluation regions. 
Structural and functional abnormalities in these regions have also been reported in UHR 
populations (Broome et al., 2009; Fusar-Poli et al., 2011; Fusar-Poli et al., 2007; 
Mechelli et al., 2011; Seiferth et al., 2008; Smieskova et al., 2010; Tognin et al., 2013). 
Furthermore, previous functional imaging studies in UHR cohorts examining emotional 
processing explicitly, using face stimuli, reported altered activation in primary sensory 
(i.e. lingual, fusiform, and middle occipital gyri) and in the prefrontal cortex relative to 
healthy controls, but not always in the amygdala (Seiferth et al., 2008; Wolf et al., 2015).  
These findings imply that emotional processing dysfunction in UHR participants may 
arise from the initial information decoding stage in sensory areas prior to engagement of 
the amygdala. However, so far the evidence is equivocal. The incentive salience 
hypothesis proposes that increased firing of dopaminergic neurons in the striatum 
enhances the salience of irrelevant stimuli in patients with schizophrenia, including 
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emotion-laden stimuli (Heinz and Schlagenhauf, 2010; Howes et al., 2009; Kapur, 2003; 
Roiser et al., 2013). It has been repeatedly demonstrated that striatal dopaminergic 
activity, including dopamine synthesis capacity and stress-induced dopamine release, is 
increased in the early phase of the illness, including FEP (Bonoldi and Howes, 2013; 
Ellison-Wright et al., 2008; Mizrahi et al., 2012) and UHR stages (Egerton et al., 2013; 
Howes et al., 2009; Mizrahi et al., 2012) These alterations are mainly observed in the 
dorsal striatum. Furthermore, increased resting perfusion, a marker of neural activity 
(Allen et al., 2015), and altered connectivity (Dandash et al., 2014) have been reported in 
the dorsal striatum (especially the caudate) in UHR cohorts. Altered striatal function 
observed in FEP and UHR individuals may contribute to altered salience responses 
(Roiser et al., 2013), including responses to emotional-laden stimuli (Winton-Brown et 
al., 2014).  
The dorsal striatum, especially the caudate nucleus, has been shown to modulate 
frontolimbic connections during valence-specific emotional processing (Diwadkar et al., 
2012; Kotz et al., 2015), particularly in response to unpleasant stimuli (Carretie et al., 
2009). Misattribution of emotionally salient stimuli has been reported in patients with 
schizophrenia during emotional processing (Cohen and Minor, 2010). Together, these 
findings implicate that altered striatal function in psychosis contributes to the valence 
misattribution of emotional-laden stimuli. It is not clear, however, if altered striatal 
function impacts on emotional valence judgment in UHR and FEP individuals. 
We investigated the neural correlates of emotion recognition in UHR and FEP subjects 
using both dynamic facial and prosodic voice stimuli. In addition to the emotional face 
stimuli used in previous studies in UHR populations (Diwadkar et al., 2012; Seiferth et 
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al., 2008), we additionally included prosodic voice stimuli; as impaired capability to 
extract non-verbal emotional information from language is widely reported in 
schizophrenia (Bach et al., 2009; Edwards et al., 2002; Edwards et al., 2001; Kucharska-
Pietura et al., 2005; Leitman et al., 2007) and high-risk populations (Addington et al., 
2012; Amminger et al., 2012a; Amminger et al., 2012b). We predicted that (1) relative to 
HC, FEP patients would show reduced recognition accuracy for both facial and prosodic 
voice stimuli across emotions, and that this would be associated with decreased activation 
throughout corticolimbic regions involved in both sensory (i.e. FG, STG) and higher 
order emotional processes (i.e. amygdala and prefrontal cortex). We additionally 
predicted (2) that relative to HC, UHR participants would show reduced recognition 
accuracy and functional alterations in this corticolimbic network, particularly in cortical 
sensory regions (i.e. FG and STG), but to a lesser extent than that seen in FEP patients. 
Finally, given the role of the caudate nucleus in the processing of negative emotional 
stimuli (Carretie et al., 2009), we explored bilateral caudate regions and predicted that (3) 
UHR and FEP participants would show increased activation in this region relative to HC 
during emotional valence judgment.   
 
 
2. METHODS 
2.1 Participants 
All participants were between 18 and 40 years of age.  Eighteen UHR participants were 
recruited from Outreach and Support in South London (OASIS) (Broome et al., 2005). 
The UHR state was defined according to the Personal Assessment and Crisis Evaluation 
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(PACE) criteria (Yung et al., 1998) and confirmed using the Comprehensive Assessment 
of At Risk Mental States (CAARMS) scale (Yung et al., 2008). In brief, UHR 
participants met at least one of the following criteria: a) attenuated psychotic symptoms; 
b) brief limited intermittent psychosis; or c) a significant decline in cognitive and social 
functioning over the past year, together with either schizotypal personality disorder or a 
first degree relative with a psychotic disorder. One of the UHR participants was taking 
atypical antipsychotic medication (the chlorpromazine equivalent was 100 mg/day).  
 
Eighteen FEP patients were recruited to the study through South London and Maudsley 
early intervention clinics (http://www.slam.nhs.uk). FEP was operationally defined as 
'first treatment contact' plus an ICD-10 diagnosis of psychosis (codes F20-F29 and F30-
F33) (World Health Organization, 1992a). The clinical diagnosis was validated by 
administering the Schedules for Clinical Assessment in Neuropsychiatry (SCAN, World 
Health Organization, 1992b), and the clinical states were in partial remission. Ten of the 
FEP participants were taking atypical antipsychotic medication (all using second 
generation antipsychotics, the chlorpromazine equivalent in those FEP participants who 
were taking antipsychotic medications was 186.66  ± 118.84 mg/day). 
 
Twenty-one gender-matched healthy control (HC) participants were recruited via 
advertisements from the same geographical areas as UHR/FEP participants. No HC 
participants met criteria for a DSM-IV-TR psychiatric disorder, fulfilled the PACE 
criteria for prodromal symptoms, or had a first-degree family history of psychiatric 
disorders. One HC was excluded due to incomplete data collection. 
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Exclusion criteria for all subjects included a history of neurological disorder, prior head 
trauma resulting in loss of consciousness and/or hospitalisation, or any contraindications 
to exposure to a magnetic field (e.g. metal implants, or pregnancy). Any participants 
reporting excessive use of alcohol (>21 units per week for men and >14 units per week 
for women) or recent recreational drug use (use of cannabis, stimulants, hallucinogens, or 
opiates in the two weeks prior to the fMRI scan) were excluded. None of the participants 
had received a DSM-IV-TR diagnosis for substance abuse or dependence.  
 
Written informed consent was obtained from all participants after detailed explanation of 
the study protocol. Ethical approval from the study was granted by the UK National 
Research Ethics Service Committee London – Bromley (reference number: 11/LO/0623).  
 
2.2 Clinical and neurocognitive assessment 
Participants’ demographic and clinical data and estimated IQ scores are presented in 
Table 1. IQ was assessed using the Wide Range Achievement Test Revised (WRAT-R) 
(Jastak and Wilkinson, 1984). Symptoms in UHR and FEP participants were assessed 
with the Positive and Negative syndrome scale (PANSS) (Kay, 1987). The Clinical 
Assessment of At Risk Mental State (CAARMS) (Yung et al., 2005) was administered to 
UHR and HC participants (Table 1). Lifetime cannabis use experience was determined by 
self-report frequency and classified into four levels: 1-experimental, 2-occasional, 3-
moderate, and 4-severe use, while non-users were coded as 0.   
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2.3 MRI Acquisition and Processing 
Functional images were acquired using a 1.5T MRI scanner (Sigma, LX-GE, Milwaukee, 
USA) at the Institute of Psychiatry, King’s College London, UK, using the following 
parameters: TR = 3000 ms, TE = 40 ms, flip angle = 90°, slice thickness = 2.5 mm with 
0.5 mm gap,  field of view = 24 cm
2
 and a 64x64 matrix. In total, 46 axial slices parallel 
to the anterior commissure–posterior commissure (AC-PC) line were collected for each 
participant.  Four hundred and twenty-seven image volumes were acquired during the 
task in each participant. Structural data were acquired using a three-dimensional T1-
weighted FSPGR sequence (voxel size: 1x1x1 mm
3
, field of view: 280, 146 slices, 
TR=11.092 ms, TE=4.87 ms, TI=300 ms, α=18°) for coregistration purposes.  
 
2.4 Emotional recognition paradigm 
We used emotional stimuli with dynamic and continuous change in facial geometric 
configuration (Platt et al., 2010) and with vocal prosodic characteristics (Nowicki and 
Duke, 1994) validated in previous studies. The details for both facial and prosodic tasks 
are described in the supplementary materials. There were 96 dynamic face trials (happy, 
sad, fearful and neutral) and 96 high-intensity voice trials (happy, sad, fearful and their 
low-intensity comparisons) of variable duration (the mean trial duration was 4.2±1.37 
seconds). Dynamic emotional stimuli were created with Abrosoft Fantamorph software 
(version 4.0). Photographs were morphed from neutral to the target emotion with 
increasing intensity within 25 frames during the ‘morph’. A one-second inter-stimulus 
interval in which a fixation-cross was presented in the centre of the screen followed each 
stimulus. During the emotion recognition task, face and voice trials were presented 
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interspersed in a pseudo-random order and arranged into two sessions. Face stimuli were 
presented on a projection screen. A fixation cross was presented during the voice trials. 
Participants were instructed to choose between four emotional categories (happy, sad, 
fearful, and neutral) via a button box as quickly as possible before the voice and/or video 
clips ended. After the morphing face and voices stopped a black screen with fixation 
cross was presented until the end of the trial. During the task, participants’ response 
accuracy was recorded.   
 
 
3. DATA ANALYSIS 
3.1 Behavioural data analyses  
Clinical and demographic data were analysed using chi-square tests (gender, handedness) 
and analyses of variance (ANOVA) (other demographic and clinical data) in IBM SPSS 
19.  Separate analyses were performed for the face trials and the voice trials. Accuracy 
scores were analysed using repeated measures analyses of covariance (RM-ANCOVAs) 
with age included as a covariate of no interest. Emotional category (happy, sad, fearful, 
neutral) was entered as the within-subjects variable. Diagnostic group was entered as the 
between-subjects variable. In addition, we explored the frequency of valence 
misrecognition between groups i.e. positive emotion (happy dynamic faces and prosodic 
voices trials) misrecognised as negative emotion (sad or fearful dynamic faces and 
prosodic voices trials). Following the detection of significant main effects or interactions, 
post-hoc t-tests or F-tests were employed and inferences were made at p<0.05. 
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3.2 Functional MRI analyses 
Functional images were pre-processed using SPM8 software 
(http://www.fil.ion.ucl.ac.uk/spm) running under Matlab 7.1 (Math Works, Natick, MA, 
USA). The full preprocessing procedures are detailed in supplementary materials.  
 
Images of both sessions were realigned to the obtained structural image. The remaining 
images were then realigned to the first image of their respective session and resliced with 
sinc interpolation. Movement parameters were calculated and images with excessive 
movement (>1.5 mm of translation and 1 degree of rotation in any axis) and the adjacent 
images were examined and removed if the image was corrupted. Interpolation between 
the images adjacent to the corrupted images was performed to replace the removed 
images. Subjects who had more than 10% of data corrupted were considered as having 
excessive movements and were excluded from the subsequent analyses. One UHR 
participant and one FEP participant were thus excluded. Images were segmented and 
spatially normalized (Friston et al., 1995) to a standard MNI-305 template using 
nonlinear-basis functions and spatially smoothed with a Gaussian kernel 8-mm full width 
at half maximum isotropic. 
 
A standard event-related first-level analysis of regional responses was performed; onset 
times (i.e. of the onset of the facial expressions or voice clips) and associated durations 
were convolved with a canonical haemodynamic response function. To exclude low 
frequency drifts a high-pass filter was applied using a set of discrete cosine basis 
functions with a cutoff of 128 sec, and an AR(1) model was applied to account for 
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temporal auto-correlation intrinsic to the fMRI time-series. The movement parameters 
were entered as separate regressors of no-interest in the first level analyses. 
 
For first level statistical analysis, ten experimental regressors were defined: 1) Happy 
Face 2); Sad Face; 3) Fearful Face; 4) Neutral Face; 5) High-intensity Happy Voice; 6) 
Low-intensity Happy Voice; 7) High-intensity Sad Voice; 8) Low-intensity Sad Voice; 9) 
High-intensity Fearful Voice; and 10) Low-intensity Fearful Voice. Five first level 
contrasts of interest were then computed for dynamic face and prosodic voice stimuli: 1) 
Happy – Comparison; 2) Sad – Comparison; 3) Fearful – Comparison; 4) All emotions – 
Comparison; and 5) Positive emotion (Happy) – negative emotion (Fearful + Sad). For 
dynamic face contrasts, neutral faces acted as the comparison condition. For prosodic 
voice trials, since the validated stimulus set (DANVA-2-AP) did not contain neutral 
voice stimuli, low-intensity voice trials served as the comparison condition (i.e. high 
versus low intensity for the same prosodic emotion).  
 
Second-level analyses were performed using two approaches: whole brain voxel-wise 
analyses for exploration of the effect of emotional processing, and region of interest 
(ROI) analyses (Li et al., 2010; Witteman et al., 2012) based on a visual and auditory 
emotional processing model in schizophrenia (Tseng et al., 2015). Whole brain analysis 
was performed using ANCOVA and independent samples t-tests (conducted within the 
SPM ANCOVA framework) with age as a covariate of no interest. Other confounding 
factors (i.e. IQ, cannabis use and antipsychotics use) were not included in the analyses as 
supplementary correlational analyses between these factors and peak activation in all 
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ROIs were non-significant within each group of participants. Statistical inferences were 
made at p<0.05 after FWE cluster-level correction for multiple comparisons. When the 
group comparison omnibus F-contrast did not reach significance, additional exploratory 
pair-wise analyses were performed to compare FEP versus HC, UHR versus HC and FEP 
versus UHR, with a corrected threshold at p<0.017 (Bonferroni corrections for 3 
contrasts), except for the exploratory hypothesis examining bilateral caudate regions 
during emotional valence judgment. For ROI analyses, a search sphere with a radius of 
16 mm (twice the smoothing kernel) was applied to the centre of each ROI using the 
small volume correction function in SPM8 (described below). Coordinates were 
described according to the standard Montreal Neurologic Institute (MNI) system.  
 
Four ROIs, identified in a meta-analysis (Li et al., 2010) of facial emotion recognition 
studies, were used to examine group effects during dynamic face trials. These were the 
bilateral FG (left, -39, -65, -13; right, 40, -52, -14), left amygdala (-21, -7, -8) and right 
lentiform gyrus (22, -3, -5). For the prosodic voice trials, primary facial decoding areas 
(bilateral FG) were replaced by primary prosodic decoding areas (bilateral STG; left, -62, 
-22, 1; right, 49,-23,6); coordinates were selected from the meta-analysis by Witteman 
and colleagues (Witteman et al., 2012). To test our valence-specific hypothesis an ROI in 
the caudate nucleus (Carretie et al., 2009), was  chosen in the left (-18, -2, 24) and right 
caudate body (16, 4, 18) (Carretie et al., 2009). Spheres were then constructed in 
MarsBaR toolbox for SPM (Brett et al., 2002). A single inclusive mask containing all 
ROIs was applied, and statistical inferences were made at p<0.05 with FWE correction 
for multiple comparisons at the voxel-level after applying small volume correction (SVC). 
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4. RESULTS 
4.1 Demographic and clinical data 
Demographic and clinical data for each group are reported in Table 1. There were 
significant age differences (F=5.86, df=(2, 54), p<0.005) with FEP patients being older 
than HC.  There were significant estimated IQ differences (F=8.47, df=(2, 54), p=0.001) 
with HC showing higher IQ scores than UHR and FEP.  There were also significant 
differences in cannabis use (F=10.10, df=(2, 54), p<0.005) with UHR having more 
cannabis use experience than HC and FEP.   
 
4.2 Dynamic Face Trials 
 
4.2.1 Recognition accuracy  
Mean accuracy scores are shown in figure 1(A). There was a significant main effect of 
emotional category (F =14.86, df =(3, 159), p<0.001). Across all participants, recognition 
accuracy was greatest for happy relative to sad (t=8.22 df=56, p<0.001) and fearful trials 
(t=6.62, df =56, p<0.001). There was a trend towards an effect of diagnostic group (F 
=2.65, df =(2, 53), p=0.08) with HC showing greater accuracy than FEP patients across 
all emotional conditions (post-hoc pairwise comparison: HC>FEP, F=5.74, df=(1,36), 
p=0.022). The group*emotional category interaction was non-significant (F=0.42, 
df=(6,159), p=0.87). 
The effect of diagnostic group for misrecognition of positive emotional faces (i.e. happy) 
as negative (i.e. sad or fearful) was also non-significant (F=1.49, df=(2, 53), p=0.24).  
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4.2.2 Functional MRI  
The main effect of task (emotional > comparison trials) is reported in the supplementary 
material. The main effect of group (emotional > neutral trials) was non-significant for 
both whole-brain and ROI analyses (Table 2). However, exploratory pair-wise group tests 
(conducted within the SPM ANCOVA framework) revealed trends towards significance 
in the right FG. In this region both FEP (t=3.62, df=51, p=0.04 SVC) and UHR groups 
(t=3.62, df=51, p=0.04 SVC) (table 2, figure 1B) showed reduced activation during 
emotional face trials relative to HC. However, the effects did not survive after correction 
for multiple comparisons (corrected threshold p<0.017). The difference between UHR 
and FEP groups did not approach significance. The group × valence (positive vs. negative 
emotions) interaction was non-significant in the caudate ROI. 
 
 
4.3 Prosodic Voice trials 
4.3.1 Recognition Accuracy  
Mean accuracy scores for prosodic voice trials are shown in figure 2A. The main effect of 
emotional category was non-significant (F =1.028, df=(3, 159), p=0.38). The main effect 
of diagnostic group was significant (F =7.96, df =(3, 159), p=0.001) across all emotional 
categories, driven by greater overall accuracy in HC relative to UHR (F =4.30, df 
=(1,36), p=0.045) and FEP (F =23.69, df =(1,36), p<0.001) groups.  The 
group*emotional category interaction (F=1.035, df=(6, 159), p=0.41) and group *valence 
interaction for misrecognition were non-significant (F=2.22, df=(2, 53), p=0.11).   
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4.3.2 Functional MRI 
The main effect of task (high intensity prosodic voices > low intensity prosodic voices) is 
reported in supplementary material. Whole-brain analysis revealed a trend towards a 
significant group effect in the left amygdala extending to left insula (Table 3, figure 2B). 
Pair-wise group comparisons revealed reduced activation in FEP patients relative to HC 
in the left amygdala, STG, medial orbital frontal gyrus, lingual gyrus and left angular 
gyrus (whole brain corrected, cluster-level) (Table 3). The difference between UHR and 
FEP groups was non-significant.  ROI analyses confirmed the group effect in left 
amygdala (F=15.08, df=(2,51), p=0.009; SVC) and in the left STG (F=12.79, df=(2,51), 
p=0.03 SVC; see Table 3 and Figure 2C). Pair-wise group tests also showed that the FEP 
patients had significantly lower activation than the HC group in the left amygdala 
(t=5.46, df=51, p=0.002 SVC) and left STG (t=5.05, df=51, p=0.003 SVC; see Table 3). 
  
The group*valence interaction were non-significant (F=9.31, df=(2, 51), p=0.17) in the 
caudate ROI. Pair-wise group comparison showed a trend group*valence interaction 
between HC and UHR in the left dorsal caudate. In this region, HC showed greater 
activation for negative relative to positive emotions but the opposite pattern was seen in 
UHR participants (positive > negative) (t=4.31, df=51, p=0.02; see Figure 3). However, 
this did not survive a Bonferroni corrected threshold of p<0.017. The group*valence 
interactions between FEP and HC groups, and between FEP and UHR groups in the 
caudate ROI were non-significant.  
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5. DISCUSSIONS 
We investigated the neural correlates of emotional processing in response to emotional 
stimuli in two sensory modalities (visual, auditory) in FEP patients, UHR and HC 
individuals. In line with our hypothesis, FEP patients showed reduced recognition 
accuracy compared to HC during dynamic face and prosodic voice trials. During dynamic 
face trials, overall recognition accuracy for UHR participants was intermediate to HC and 
FEP patients but did not differ significantly from either group. During prosodic voice 
trials, however, UHR participants showed significantly reduced recognition accuracy 
relative to HC, while significantly reduced accuracy for fearful voice trials in UHR was 
observed (Figure 2(A)). Of note, the vocal fear recognition rate was relatively low, which 
might reflect its higher ambiguity (i.e. lower accuracy and longer reaction times, see 
Edwards et al., 2002; Tseng et al., 2013) and thus susceptible to both time-urgent design 
(requiring participant to respond as soon as possible before the clip ended) and the 
background noise during image acquisition. Nevertheless, these factors affected all three 
groups and the results remain consistent with previous studies (Amminger et al., 2012a; 
Hoekert et al., 2007; Kohler et al., 2010; Thompson et al., 2012) that show impaired 
emotion recognition in people at clinical high-risk for schizophrenia before the full 
expression of psychotic illness.  
 
The majority of previous studies in schizophrenia (Lee et al., 2002; Li et al., 2010; 
Pinkham et al., 2005; Reske et al., 2009) report reduced amygdala activity in patients 
with schizophrenia. However, contrary to previous findings and our hypotheses, we did 
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not find a significant group difference in brain activation during dynamic face trials. 
Using a relatively low magnetic field scanner (1.5T rather than 3T) may have contributed 
to the lack of differences in activation between groups. We used a low-field scanner to 
mitigate the loud noise generated by high-field scanners, which may interfere with the 
processing of acoustic stimuli. Nevertheless, the lack of activation differences in response 
to emotional face stimuli is consistent with a small number of previous studies that did 
not find clear amygdala activation differences in schizophrenia relative to healthy 
controls (Sachs et al., 2012; Swart et al., 2013). Our findings may suggest that relatively 
intact facial emotional processing is also seen in early and prodromal stages of psychosis. 
 
Despite that the group comparison of brain activation during dynamic face trials did not 
reach statistical significance, exploratory pair-wise ROI analysis of functional MRI data 
showed a non-significant trend of reduced right FG activation in FEP patients relative to 
HC. During prosodic voice trials, a more widespread pattern of reduced activation was 
apparent in FEP patients relative to HC, involving both sensory (STG) and emotional 
processesing regions (amygdala and medial orbital prefrontal cortex), and also left 
temporal-parietal-limbic regions, including left MTG, left insula, and left thalamus. 
Dysfunction in cortical and limbic brain regions that are involved in sensory (i.e. FG, 
STG), information relaying and modulation (i.e. basal ganglia/caudate), and higher order 
emotional processes (i.e. amygdala and prefrontal cortex) in patients with schizophrenia 
has been established robustly (Lee et al., 2002; Li et al., 2010; Tian et al., 2011).  Our 
findings complement those of schizophrenia studies, and confirm previous studies 
reporting functional changes in these corticolimbic regions, involved in both early 
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decoding and emotional recognition/interpretation, in FEP population (Reske et al., 2009; 
Reske et al., 2007).  
  
In FEP patients the deactivation (negative contrast estimates) indicate greater activation 
to neutral rather than emotional stimuli in corticolimbic regions (Figure 1(C) and 2(C)), 
and could be interpreted as hyperactivation to neutral or subtle emotional stimuli as 
previously reported in schizophrenia populations (Aleman and Kahn, 2005; Hall et al., 
2008; Modinos et al., 2015; Seiferth et al., 2008). This functional change would be 
consistent with the notion that non-emotional information is more salient in FEP and at-
risk states. Such abnormalities are thought to contribute to the social cognition and social 
functioning deficits apparent in emerging psychotic disorders (Amminger et al., 2012b).  
 
Relative to HC, despite a showing a non-significant trend for reduced activation in the 
sensory cortex (right FG) during emotional versus neutral dynamic face trials, UHR 
participants did not show significant difference in either face or voice modalities. 
Similarly, intermediate BOLD response between HC and FEP was observed in UHR 
participants in those areas showing decreased activation in the FEP group during prosodic 
voice trials, albeit the difference between HC and UHR did not reach statistical 
significance. This task-related subtle functional changes in the brain in the UHR 
participants is consistent with previous studies (Dutt et al., 2015). We speculate that these 
trends may reflect early subtle changes in primary sensory emotional processing regions, 
which may manifest in vulnerability states before the full-blown onset of psychosis. 
However, this requires testing in a larger sample. 
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Interestingly, although the majority of studies in patients with schizophrenia report 
corticolimbic dysfunction during the presentation of emotional face stimuli, our findings 
in FEP patients suggest dysfunction that is more evident during the presentation of 
prosodic voice stimuli instead of facial stimuli. The reasons for this are not entirely clear 
but it is possible that as the emotional information carried in prosodic voices delivers 
more subtle interpersonal social cues than faces, voice stimuli may provide a more 
sensitive method to investigate functional alteration related to emotional recognition 
deficits in FEP and UHR cohorts. Our results support the findings of previous studies that 
reported reduced accuracy for prosodic emotional recognition in FEP and UHR groups 
(Amminger et al., 2012a) and suggest that prosodic emotional, rather than facial, stimuli 
may be better able to reveal the subtle emotional processing deficits associated with early 
psychosis and vulnerability states.   
 
The FG and the STG have been hypothesized to extract facial features and acoustic 
properties from visual and speech input, respectively, during stage 1 of the model 
proposed by Wildgruber and colleagues (Wildgruber et al., 2009). Although the current 
findings do not unequivocally support an impairment in these primary sensory processing 
areas in UHR, early subtle changes may have presented at the initial perceptual stage and 
impact on emotion recognition accuracy. By contrast, during both dynamic face and 
prosodic voice trials, activation in cortical regions (i.e. amygdala and OFC) involved in 
emotional recognition and interpretation was not significantly reduced in UHR 
participants relative to HC. This supports the view that corticolimbic hypoactivation 
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(particularly in the amygdala) during the processing of emotion is related to the disease, 
rather than vulnerability states (Rasetti et al., 2009) and is constant with previous 
neuroimaging studies in UHR cohorts that also failed to detect amygdala dysfunction in 
the context of emotional recognition (Seiferth et al., 2008).  
 
In line with our exploratory hypothesis, UHR participants showed a trend towards an 
interaction in the caudate nucleus relative to HC when processing the valence of prosodic 
voices. In HC, caudate activation was greater for negative relative to positive valence 
trials, consistent with finding from a previous study by Carretie and colleagues (Carretie 
et al., 2009). The opposite pattern of activation was seen in UHR participants suggesting 
altered caudate function during emotional processing. Altered striatal activation in UHR 
populations has been reported previously during a salience processing task (Roiser et al., 
2013) and may be related to elevated dopamine synthesis capacity in the associative 
striatum (Howes et al., 2009).  Inappropriate activation in the caudate during the 
presentation of emotional stimuli could result in confusion regarding the salience and/or 
valence of emotional stimuli, although this was not seen at a behavioral level in UHR 
participants.   
 
6. LIMITATIONS 
The main limitation of the present study is the relatively small sample size: our findings 
will need to be replicated in larger FEP and UHR cohorts. The age difference between 
HC and FEP was another limitation. However, we included age as a covariate in all 
analyses to address this issue.  
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Several potential confounding factors needs further discussion. First, the three groups 
were not matched for estimated pre-morbid IQ and our experimental task required 
explicit emotion recognition under a time constraint which may have been cognitively 
demanding (Phan et al., 2002). However, to our knowledge, although performance of 
emotion recognition may be associated with specific cognitive deficits (Bryson et al., 
1997), there is no evidence that general intelligence significantly affects emotional 
processing (Coan and Allen, 2007).  Furthermore, we chose not to control for IQ in the 
main analysis since this may remove important variance (Edwards et al., 2002) between 
groups, as low IQ is a phenotypic characteristic of psychosis (Mesholam-Gately et al., 
2009). A supplementary correlation analyses showed that the peak activation in all ROIs 
did not correlate with IQ within any of the groups, suggesting that IQ was not a major 
confounding factor for emotional processing. 
 
A further limitation is that one UHR participant and a number of FEP patients that 
participated in the study were taking low doses of antipsychotic medication. Although 
most studies in patients with schizophrenia suggest that medication is not a major 
confounding influence on emotional recognition accuracy (Fusar-Poli et al., 2007; Navari 
and Dazzan, 2009), the influence of antipsychotic medication on hemodynamic responses 
during emotional processing remains unclear. Nevertheless, supplementary correlation 
analyses showed that the peak activation in all ROIs did not correlate with 
chlorpromazine equivalent dose in our FEP participants. Likewise, the higher lifetime 
experience of cannabis use in the UHR cohort, relative to both FEP and HC groups is 
also a potential confounder, given that chronic heavy cannabis use may affect emotional 
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recognition accuracy (Hindocha et al., 2014; Platt et al., 2010). However, none of our 
UHR cohort reported concurrent heavy cannabis use nor met the DSM-IV diagnostic 
criteria for neither cannabis abuse nor dependence. A supplementary correlation analyses 
showed that the peak activation in all ROIs did not correlate with cannabis use within any 
of the groups, supporting the view that cannabis use did not affect the results.  
Another potential limitation is using low-intensity emotional prosodic stimuli as the 
contrast instead of neutral ones. It is arguable that the contrast of high versus low 
intensity for voice stimuli may reflect an intensity or arousal effect rather than emotion 
itself. In our study design it would not be possible to differentiate these two effects. 
However, as intensity is an important dimension of emotional information, these 
contrasts should still evoke the neural correlates of emotional processing, independent of 
their low-level acoustic properties (Ethofer et al., 2006). 
 
7. CONCLUSIONS 
In summary, FEP patients showed emotional recognition deficits and functional 
alterations in corticolimbic regions consistent with deficits across a multi-stage emotional 
processing model, mainly in the voice modality. By contrast, while UHR participants also 
showed emotional recognition deficits behaviourally, we only observed a trend towards 
an interaction in the neural processing of emotional stimuli in caudate nucleus, with a 
non-significant decrease of activation in early sensory processing regions. Our results 
highlight the need to investigate behavioral and neural vulnerability biomarkers in 
psychosis-prone high-risk populations in larger samples, and to expand the etiological 
understanding of psychosis and consequently provide insights for preventive strategies. 
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Future longitudinal studies are needed to fully understand the chronology of emotional 
and corticolimbic dysfunction in the development of psychosis.  
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TABLE LEGENDS 
Table 1.  Demographic information for participants across diagnostic group and 
statistical analysis. Means are followed by the standard deviations (in brackets). 
 
Table 2.  Whole brain voxel-wise analyses and ROI analyses using small volume 
correction for dynamic faces. Results reported for whole brain F-tests and ROI analyses 
are FWE corrected at the voxel level, p<0.05.  
 
Table 3.  Whole brain voxel-wise analyses and ROIs analyses using small volume 
correction for prosodic voices. Results reported for whole brain F-tests and ROI analyses 
are FWE corrected at the voxel level, p<0.05. Results reported for whole brain t-tests are 
FWE corrected at the cluster level, p<0.05; clusters formed at p<0.001 (minimum cluster 
size=293). 
 
Table 4.  Caudate ROIs analyses for valence-specific hypothesis. Results are FWE 
corrected at the voxel level, p<0.05. 
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FIGURE LEGENDS 
Figure 1. Dynamic face trials. (A) Graph showing mean accuracy for group by emotional 
category. (B) Statistical Parametric Map (SPM) showing group activation differences 
(HC>UHR+FEP) within right FG. The left side of the brain is on the left side of the 
image. (C) Graph showing peak BOLD activation level in right FG for each group during 
emotional dynamic faces contrasted against neutral dynamic faces, MNI coordinates (36, 
-50, -6).  HC: Healthy Control group. UHR: Ultra-High Risk Group. FEP: First-Episode 
Psychosis group.  
 
Figure 2. Prosodic voice trials. (A) Graph showing mean accuracy for each group by 
emotional category. Comparison refers to low-intensity voices. (B) SPM showing group 
activation differences (HC> FEP). The left side of the brain is on the left side of the 
image. (C) Graph showing peak BOLD activation level for each group during high 
intensity prosodic voices contrasted against low intensity prosodic voices in regions 
showing pair-wise differences between HC and FEP. HC: Healthy Control group. UHR: 
Ultra-High Risk Group. FEP: First-Episode Psychosis group. 
 
Figure 3. ROI analyses of left caudate nucleus body showing peak BOLD activation 
level for positive>negative prosodic voices in UHR>HC. HC: Healthy Control group. 
UHR: Ultra-High Risk Group. 
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Table 1   
 HC (n=21) UHR (n=18) FEP (n=18) F / χ p value 
Age (years) 22.91±3.79 24.44±4.12 27.72±5.36 5.86 
0.005  
FEP>HC 
Gender 8M:13F 10M:8F 13M:5F 4.57 0.10 
Laterality 21R:1L 17R:1L 17R:1L 0.17 0.99 
Years of 
Education 
16.71±2.10 14.89±1.94 14.78±3.98 3.03 0.06 
Cannabis Use 0.76±0.83 2.28±1.02 1.39±1.29 10.10 
<0.001 
HC=FEP<UHR 
Verbal IQ 
WRAT-R(SS) 
 
110.33±9.78 99.06±15.61 
92.11±15.3
9 
8.47 
0.001 
HC>UHR=FEP 
PANSS total - 53.88 ±11.03 
54.56 
±13.79 
0.25 0.88 
PANSS positive - 12.60±2.92 13.47±5.29 0.39 0.54 
PANSS 
negative 
- 14.39±6.24 13.17±5.45 0.04 0.85 
PANSS general - 26.73±5.35 27.00±7.36 0.00 0.98 
CAARMS total 2.33±3.81 36.29±18.29 - 69.13 <0.001 
CAARMS 
positive 
0.57±1.08 7.72±4.87 - 42.97 <0.001 
CAARMS 
emotion 
0.05±0.22 2.50±3.02 - 13.87 0.001 
 
HC = Healthy Controls; UHR = individuals at ultra-high risk state for psychosis; FEP = individuals with first episode 
psychosis; M = males; F = females; R = Predominantly Right Handed; L = Predominantly Left Handed; WRAT-R (SS) 
= Wide Range Achievement Test Revised (Standardized Score); PANSS = Positive and Negative Syndrome Scale;  
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Table 2 Face trials 
All p-values reported for ROI analyses are FWE corrected at the voxel level  
 
  
ANCOVA Group contrasts 
for Dynamic Face trials 
 No. of 
voxels x y z 
Maximum 
F values 
Z p value 
1) F-test (whole-brain) 
No clusters reach threshold 
2) F-test (ROIs) 
No voxels survive correction 
 
t-tests: Group contrasts for 
Dynamic Face trials 
 No. of 
voxels x y z 
Maximum 
T values 
Z p value 
3) t-test  whole-brain (HC vs FEP) 
No clusters reach threshold 
4) t-test ROI (HC vs FEP) 
Right fusiform gyrus, 
HC>FEP 
 
7 36 -50 -6 3.62 3.40 0.039 
5) t-test whole-brain (HC vs UHR) 
No clusters reach threshold 
6) t-test ROI (HC vs UHR) 
Right fusiform gyrus, 
HC>UHR 
 
21 34 -48 -6 3.62 3.40 0.039 
7) t-test whole-brain (UHR vs FEP) 
No clusters reach threshold 
8) t-test ROI (UHR vs FEP) 
No voxels survive correction 
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Table 3 Voice trials 
All p-values reported for voxel-wise whole brain group analyses are FWE corrected at the voxel level, p<0.05.  
ANCOVA Group contrasts 
for prosodic Voice trials 
 No. of 
voxels x y z 
Maximum 
F values 
Z p value 
1) F-test (whole-brain) 
No clusters reach threshold 
         
2) F-test (ROIs)         
Left amygdala  4 -32 -2 -18 15.08 4.34 0.009 
  4 -20 -2 -14 12.57 3.97 0.036 
Left superior temporal 
gyrus 
 
4 -54 -26 -10 12.79 4.00 0.032 
         
t-tests: Group contrasts for 
prosodic Voice trials 
 No. of 
voxels x y z 
Maximum 
T values 
Z p value 
3) t-test voxel wise (HC vs FEP) 
HC>FEP         
Left amygdala  458 -32 0 -18 5.62 4.93 0.009 
   -20 -2 -14 4.99 4.48  
Left superior temporal 
gyrus 
 
416 -54 -26 -10 5.00 4.49 0.013 
Medial orbital frontal gyrus  599 -2 54 -6 4.93 4.44 0.003 
  293 16 -60 -36 4.66 4.23 0.044 
Left lingual gyrus  1004 -2 -40 40 4.30 3.96 <0.001 
Left angular gyrus  338 -22 -62 -36 4.20 3.87 0.028 
         
4) t-test ROI  (HC vs FEP) 
HC>FEP         
Left amygdala 76 -32 -2 -18 5.46 4.82 0.002 
  -20 -2 -14 4.95 4.45 0.005 
Left superior temporal gyrus 63 -54 -26 -10 5.05 4.53 0.003 
5) t-test voxel wise (HC vs UHR) 
No clusters reach threshold 
6) t-test ROI (HC vs UHR) 
No voxels survive correction 
7) t-test voxel wise (UHR vs FEP) 
No clusters reach threshold 
8) t-test ROI (UHR vs FEP) 
No voxels survive correction 
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All p-values reported for whole brain pair-wise comparisons are FWE corrected at the cluster level, p<0.05; cluster size >= 293. 
Clusters are formed at p<0.001, uncorrected. 
*  All p-values reported for ROI analyses are FWE corrected at the voxel level , p<0.05. 
 
Table 4 ROI analyses of caudate area 
All p-value reported for ROI analyses are FWE corrected at the voxel level  
 
 
 
 
  
ROIs  
x y z 
Maximum 
T values 
Z p value 
     FWE corrected 
Positive valence Faces >  Negative valence Faces, UHR > HC 
No voxels survive correction 
 
Positive valence Voices >  Negative valence Voices, UHR > HC 
Left caudate body  -18 -2 24 4.31 3.96 0.02 
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Highlights 
• Emotional processing deficits in psychosis is linked to corticolimbic dysfunction. 
• Corticolimbic dysfunction is less studied at ultra-high risk stage for psychosis. 
• Both UHR and FEP groups showed impaired emotion recognition accuracy.  
• Reduced activation across corticolimbic networks is observed in FEP group.  
• Subtle corticolimbic dysfunction may also exist in UHR cohort.  
